Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Barfresh Food Group Inc. reported a 190% year-over-year revenue increase in Q2 2026 to $4.7 million driven by its Arps Dairy acquisition. However, slower-than-expected production efficiency and facility startup challenges led to a gross loss and higher net loss compared to the prior year. The company revised its full-year 2026 guidance downward, ex…
Thunder Bridge Capital Partners V, Ltd., a special purpose acquisition company (SPAC), successfully closed its IPO raising $300.15 million on Nasdaq under the ticker TBCVU. The units include Class A shares and redeemable warrants, with plans for separate trading under distinct symbols. The company aims to focus its search for an initial business co…
Cue Biopharma, a clinical stage biopharmaceutical company focused on immune-mediated diseases, reported significant second quarter 2026 financial results including increased revenues from collaborations, one-time non-cash and transaction-related expenses due to licensing agreements, and a net loss of $153.1 million. The company submitted an Investi…
Cemtrex, Inc. posted a 9% year-over-year revenue increase to $18.4 million in Q3 FY2026, alongside narrowing its operating loss to $1.2 million and improving operating EBITDA to a $0.6 million loss. The Security segment reduced losses significantly, approaching breakeven, while Aerospace & Defense segment profitability improved markedly. Positive o…
LeonaBio reported Q2 2026 financial results and provided updates on its oncology and neurodegeneration drug development programs. The company is on track to complete enrollment of its Phase 3 ELAINE-3 trial evaluating lasofoxifene in ER-positive, HER2-negative, ESR1-mutated metastatic breast cancer by Q4 2026, with topline data expected in the seco…
BioStem Technologies, a regenerative medicine company specializing in perinatal tissue allografts, announced its management will present at the Sidoti MicroCap Virtual Conference on August 19, 2026. The presentation will highlight the company's innovative processing technologies and expanding clinical and commercial footprint.
Femasys Inc. announced its quarterly financial results for Q2 2026, highlighting a completed $30 million private placement to support its U.S. commercial strategy and clinical development of its fertility and birth control products. The company resumed compliance with Nasdaq listing rules, achieved patent expansions, and received CE Mark approval f…
Ambow Education Holding Ltd. announced its unaudited financial results for the first half and second quarter of 2026, showing a slight 2.0% increase in first half net revenues driven by educational programs, despite a 14.3% revenue decline in Q2 primarily due to decreased HybriU licensing. The company improved gross profit margins and maintained po…
Malibu Boats, Inc. announced it will release its Q4 and full-year fiscal 2026 financial results on August 27, 2026 before market open. The company will host a conference call led by its CEO and CFO to discuss the results. Malibu is a leading manufacturer of recreational powerboats with multiple well-known boat brands.
Hydrofarm Holdings Group, Inc. announced its second quarter 2026 financial results showing a 40.9% decline in net sales to $23.2 million compared to the prior year due to industry oversupply and brand discontinuations. Despite lower sales, gross profit margins improved driven by a focus on proprietary brands, and adjusted SG&A expenses decreased by…
DarkIris Inc. announces significant advancements in its AI technology ecosystem, commercialization of its AI platform suite, and steady growth in its digital gaming business with 13.9% revenue increase year over year. The company is also progressing on AI-powered film production and strategic partnerships, positioning itself strongly in the AI-driv…
Ebang International Holdings Inc. announced its unaudited financial results for the first half of fiscal year 2026, recording a 9.54% increase in total net revenues to $3.92 million and turning a prior year gross loss into gross profit. Despite revenue growth and operational progress in renewable energy and digital infrastructure sectors, the compa…
Precipio, Inc., a specialty cancer diagnostics company, announced strong financial results for Q2 2026, achieving record revenue of $7.0 million, a 22% year-over-year increase. The company also reported a positive adjusted EBITDA of $0.4 million and improved cash flow with a cash balance exceeding $3 million. The quarterly progress reflects growing…
Beam Global, a Nasdaq-listed sustainable technology company, will release its Q2 2026 operating results after market close on August 19, 2026. The management will host a conference call to discuss financial results and corporate updates, including a Q&A session. The company specializes in energy storage, sustainable transportation, and smart city i…
60 Degrees Pharmaceuticals announced its financial results for Q2 2026, showing a 106% increase in net product revenues to approximately $208,000 compared to Q2 2025. Despite revenue growth and a slight increase in gross profit, the company reported a net loss attributable to common stockholders of approximately $2.40 million, wider than the previo…
CTS Corporation announced a cash dividend of $0.04 per share on its common stock, payable on October 23, 2026, to shareholders of record on September 25, 2026. The announcement corrected the record year from 2025 to 2026. CTS is a designer and manufacturer of sensors, actuators, and electronic components serving aerospace/defense, industrial, medic…
Danaher is trading near $203 after a sharp, emotion-driven sell-off in July. Fundamentals remain intact: $5.5B in free cash flow, a manageable debt profile, and improving equipment order momentum. If management can convert acquisitions and delayed consumable shipments into organic growth in 2027, upside to the $240s becomes likely. This trade lays …
KLA (KLAC) plunged from its late-June peak in a broad semiconductor correction. Fundamentals remain intact: high free cash flow ($3.77B trailing), strong returns (ROE 76%), and AI-driven capital spending that underpins equipment demand. Technicals show constructive momentum and a more attractive entry near $204. We recommend a swing trade with an e…
HCW Biologics Inc. reported Q2 2026 financial results showing increased revenues mainly from licensing agreements, detailed preliminary human data from its Phase 1 clinical trial of HCW9302 for alopecia areata, reacquisition of ex vivo rights for commercial-ready molecules, and ongoing development efforts for a T-cell engager for solid tumors. The …
Albemarle ($135.63) is already pricing in a recovery, but with lithium near $20/kg and the company generating roughly $1.34B in free cash flow on a $16B market cap, we see a practical mid-term trade with asymmetric upside. Entry $135.63, target $170.00, stop $118.00 — horizon: mid term (45 trading days).
The U.S. Securities and Exchange Commission has submitted a proposal to the White House that would relax aspects of its pay-to-play rule, which can bar investment advisers from managing state and local public pension assets after political donations. The rule change is at an early stage and regulators are seeking public feedback. Supporters cite un…
Zoetis's top-line growth has clearly slowed and the stock has re-rated hard after a string of disappointing Companion Animal updates and related litigation. At roughly $30.6B market cap, a P/E near 12 and P/FCF ~13 leave room for total-return upside if demand stabilizes or the company executes margin leverage. This is a tactical long with controlle…
Boyd Group Services (BYD) is a large, Canada-headquartered consolidator in auto collision repair and related services. After several years of outperformance, shares have softened; we view the current setup as a tactical long opportunity with defined risk controls. Our trade aims to capture reacceleration in organic volumes and margin recovery as in…
ServiceTitan's targeted rollout of Max AI features is already tightening margins while preserving 25%+ top-line growth. The stock has repriced after AI fears, creating a setup where accelerating gross margins and steady free cash flow can drive a re-rating. This trade idea lays out an entry at $90.81, a $118 target and a $78 stop, with a long-term …
Covista (CVSA) combines recurring education revenue, solid free cash flow, and manageable leverage. With the stock trading near $131 and fundamentals showing room for margin upside, a disciplined long trade offers asymmetric reward if enrollment and operating efficiency continue to improve.
